APA (7th ed.) Citation

Fensterer, H., Märten, A., Ebert, M., & Hofheinz, R. (2013). Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP). Annals of oncology, 24(10), .

Chicago Style (17th ed.) Citation

Fensterer, Heiko, Angela Märten, Matthias Ebert, and Ralf-Dieter Hofheinz. "Multicenter Phase II Trial to Investigate Safety and Efficacy of Gemcitabine Combined with Cetuximab as Adjuvant Therapy in Pancreatic Cancer (ATIP)." Annals of Oncology 24, no. 10 (2013).

MLA (9th ed.) Citation

Fensterer, Heiko, et al. "Multicenter Phase II Trial to Investigate Safety and Efficacy of Gemcitabine Combined with Cetuximab as Adjuvant Therapy in Pancreatic Cancer (ATIP)." Annals of Oncology, vol. 24, no. 10, 2013.